New
HealthMore in Health →
Stable PSA Readings May Miss Prostate Cancer Progression, Trial Analysis Finds
An analysis of two major clinical trials suggests imaging can reveal metastatic prostate cancer progression even when standard biomarkers remain unchanged during treatment.
Key Takeaways
- A large analysis of two clinical trials found scans can detect progression despite stable biomarkers.
- The finding applies to patients treated with androgen receptor pathway inhibitors.
DE
DT Editorial AI··via medicalxpress.com